Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC20462	MNK-IN-54	MNK-IN-54 is a potent, orally bioavailable dual MNK1/2 and BCR-ABL1 inhibitor with IC50 of 20/10/200/10 nM for Abl T315I/ wt Abl/MNK1/MNK2, respectively.
DC12496	Mofezolac Featured	Mofezolac is a Highly Selective Cyclooxygenase-1 Inhibitors,Counteracting Inflammatory State both In Vitro and In Vivo Models of Neuroinflammation.
DCAPI1029	Moguisteine Featured	Moguisteine is a novel peripheral non-narcotic antitussive drug.
DC9425	Molindone (hydrochloride)	Molindone is a therapeutic antipsychotic, used in the treatment of schizophrenia, works by blocking the effects of dopamine in the brain, leading to diminished psychoses.
DC22320	Mollugin Featured	Mollugin is a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway.
DC8991	Molsidomine	Molsidomine is an orally active, long acting vasodilating drug, metabolized in the liver to the active metabolite linsidomine, which is an unstable compound that releases nitric oxide (NO) upon decay as the actual vasodilating compound.
DCAPI1363	Mometasone furoate	Mometasone furoate
DCAPI1006	Monobenzone (Benoquin)	Monobenzone (Benoquin)
DC7690	MMAD Featured	Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is a toxin payload in antibody drug conjugate.
DC7685	MMAF Featured	Monomethylauristatin F(MMAF) is an antitubulin agent that inhibit cell division by blocking the polymerization of tubulin; lower cytotoxic activity than MMAE; antibody drug cytotoxin.
DC20042	Monooctyl succinate	Monooctyl succinate is a monoester, which can be used as a surfactants and a potential fragrance releaser.
DC8931	Mosapride	Mosapride is a gastroprokinetic agent that acts as a selective 5HT4 agonist.
DC12485	Mosedipimod	Mosedipimod (EC-18, 1-palmitoyl-2-linoleoyl-3-acetylglycerol) is a synthetic monoacetyldiaglyceride that stimulates T cell production of IL-2, IL-4, IL-12, IFN-γ, and GM-CSF in vitro.
DCAPI1331	Moxonidine	Moxonidine
DCAPI1572	Moxonidine hydrochloride	Moxonidine hydrochloride
DC22554	MP-A08	MP-A08 is a first-in-class, highly selective, ATP competitive sphingosine kinase (SphK) inhibitor (Ki of 6.9/27 uM for SK2/SK1).
DC22290	Aranidipine (MPC1304) Featured	MPC1304 is a Ca2+ channel antagonist with potent and long-lasting antihypertensive effects. IC50 & Target: Ca2+ Channel.
DC8339	MPEP hydrochloride Featured	MPEP is a potent, highly selective non-competitive antagonist at the mGlu5a receptor subtype (IC50 = 36 nM) while having no agonist or antagonist activities at the mGlu1b receptor at concentrations up to 30 μM.
DC1015	MPEP Featured	MPEP is a selective mGlu5 receptor antagonist with IC50 of 36 nM.
DC20464	mPGES1-IN-16	mPGES1-IN-16 is a potent and selective mPGES-1 inhibitor with IC50 of 1 nM.
DC20465	mPGES1-IN-17d	mPGES1-IN-17d is a potent, selective mPGES-1 inhibitor with enzyme IC50 of 8 nM, A549 cell IC50 of 16.24 nM, human whole blood IC50 of 249.9 nM.
DC23974	Mps1-IN-3 Featured	Mps1-IN-3 is a selective and highly potent Mps1 kinase inhibitor with IC50 of 50 nM.
DC9542	MPTP (hydrochloride) Featured	MPTP HCl induced reduction in the DOPAC HVA/dopamine (DA) ratio and increase in striatal ascorbate (AS) oxidation in rats
DC23877	MRK-560	MRK-560 is a potent, brain-penetrant and orally bioavailable γ-secretase inhibitor that inhibits proteolytic cleavage of APP over the Notch pathway.
DC23655	MRK-623	MRK-623 is a potent, α2/α3 subunit functionally selectiviie GABAA receptor agonist..
DC23616	MRK-696	MRK-696 is a non-selective benzodiazepine receptor partial agonist..
DC21923	MRK-A	MRK-A is a potent, highly selective, brain penetrant inhibitor of mutant IDH1 with IC50 of 5 nM, displays a 10,000-fold mutant to wildtype selectivity ratio.
DC21343	MRL-1237	MRL-1237 is a potent and selective inhibitor of the replication of Enteroviruses with EC50 of 1-10 uM, targets the nonstructural 2C protein.
DC23711	MRL20	MRL20 is a novel synthetic PPARγ ligand and orthosteric agonist with canonical LBP binding affinity of 2 nM.
DC20220	MRS-1845 Featured	MRS 1845 is a potent calcium channel protein inhibitor and inhibits capacitative Ca2+ influx in HL-60 cells (IC50 = 1.7 mM).

Other Targets

Customized Consultation X

Your information is safe with us. * Required Fields.